Novartis AG ADR [NVS] stock prices are down -0.12% to $135.03 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The NVS shares have gain 3.07% over the last week, with a monthly amount glided 2.87%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Novartis AG ADR [NYSE: NVS] stock has seen the most recent analyst activity on December 08, 2025, when JP Morgan upgraded its rating to an Overweight. Previously, Morgan Stanley upgraded its rating to Overweight on December 03, 2025. On November 25, 2025, upgrade upgraded it’s rating to Buy. Goldman downgraded its rating to a Sell but stick to its price target of $118 on September 12, 2025. Morgan Stanley upgraded its rating to a Equal-Weight but $123 remained the price target by the analyst firm on August 08, 2025. UBS downgraded its rating to Neutral for this stock on February 13, 2025. In a note dated February 12, 2025, Morgan Stanley initiated an Underweight rating.
The stock price of Novartis AG ADR [NVS] has been fluctuating between $96.06 and $135.27 over the past year. Currently, Wall Street analysts expect the stock to reach $127 within the next 12 months. Novartis AG ADR [NYSE: NVS] shares were valued at $135.03 at the most recent close of the market. An investor can expect a potential drop of -5.95% based on the average NVS price forecast.
Analyzing the NVS fundamentals
The Novartis AG ADR [NYSE:NVS] reported sales of 54.46B for trailing twelve months, representing a surge of 7.04%. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at 0.31%, Pretax Profit Margin comes in at 0.29%, and Net Profit Margin reading is 0.26%. To continue investigating profitability, this company’s Return on Assets is posted at 0.13, Equity is 0.34 and Total Capital is 0.23. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 134.07 points at the first support level, and at 133.10 for the second support level. However, for the 1st resistance point, the stock is sitting at 136.33, and for the 2nd resistance point, it is at 137.62.
Ratios To Look Out For
It’s worth pointing out that Novartis AG ADR [NYSE:NVS]’s Current Ratio is 0.88. Further, the Quick Ratio stands at 0.68, while the Cash Ratio is 0.3. Considering the valuation of this stock, the price to sales ratio is 4.70, the price to book ratio is 5.84 and price to earnings (TTM) ratio is 18.41.
Transactions by insiders
Recent insider trading involved Marshall Fiona, Officer, that happened on May 23 ’25 when 15000.0 shares were purchased. Officer, Kowalski Robert William completed a deal on Apr 30 ’25 to buy 1212.0 shares.
